The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Intravenous Iron Optimizes the Response to Recombinant Human Erythropoietin in Cancer Patients With Chemotherapy-Related Anemia: A Multicenter, Open-Label, Randomized Trial
Abstract
Purpose: Recombinant human erythropoietin (rHuEPO) is the standard of care for patients with chemotherapy-related anemia. Intravenous (IV) iron improves hemoglobin (Hb) response and decreases dosage requirements in patients with anemia of kidney disease, but its effect has not been studied in randomized trials in cancer patients. Methods: This prospective, multicenter, open-label, randomized trial enrolled 157 patients with chemotherapy-related anemia (Hb ≤ 105 g/L, serum ferritin ≤ 450 pmol/L or ≤ 675 pmol/L with transferrin saturation ≤ 19%) receiving subcutaneously rHuEPO 40,000 U once weekly to: (1) no-iron; (2) oral iron 325 mg twice daily; (3) iron dextran repeated 100mg IV bolus; or (4) iron dextran total dose infusion (TDI). Hb and quality of life (QOL) were measured at baseline and throughout. Results: All groups showed Hb (P < .0001) increases from baseline. Mean Hb increases for both IV iron groups were greater (P < .02) than for no-iron and oral iron groups. The percentage of patients with hematopoietic responses was higher (P < .01) in both IV iron groups (each case 68%) compared with no-iron (25%) and oral iron (36%) groups. IV iron groups showed increases in energy, activity, and overall QOL from baseline, compared with a decrease in energy and activity for no-iron group and no change in activity or overall QOL for oral iron group. Conclusion: rHuEPO increases Hb levels and improves QOL in patients with chemotherapy-related anemia. Magnitude of Hb increase and QOL improvement is significantly greater if IV iron is added.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Henke, M., Laszig, R., Rübe, C., Schäfer, U., Haase, K.-D., Schilcher, B., Mose, S., Beer, K. T., Burger, U., Dougherty, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14567-9 · Cited by 1,250
Littlewood, T. J., Bajetta, E., Nortier, J. W. R., Vercammen, E., Rapoport, B., & for the Epoetin Alfa Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.11.2865 · Cited by 974
Chemotherapy-Induced Anemia in Adults: Incidence and Treatment
Groopman, J. E., & Itri, L. M. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.19.1616 · Cited by 929
Demetri, G. D., Kris, M., Wade, J., Degos, L., & Cella, D. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3412 · Cited by 751
Glaspy, J., Bukowski, R., Steinberg, D., Taylor, C., Tchekmedyian, S., & Vadhan-Raj, S. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.1218 · Cited by 693
Progress in understanding the pathogenesis of the anemia of chronic disease [see comments]
Means, R. J., & Krantz, S. (1992) · Blood · doi:10.1182/blood.v80.7.1639.1639 · Cited by 681
Decreased Erythropoietin Response in Patients with the Anemia of Cancer
Miller, C. B., Jones, R. J., Piantadosi, S., Abeloff, M. D., & Spivak, J. L. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006143222401 · Cited by 658
Gabrilove, J. L., Cleeland, C. S., Livingston, R. B., Sarokhan, B., Winer, E., & Einhorn, L. H. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.11.2875 · Cited by 595
A randomized controlled study of iron supplementation in patients treated with erythropoietin
Macdougall, I. C., Tucker, B., Thompson, J., Tomson, C. R. V., Baker, L. R. I., & Raine, A. E. G. (1996) · Kidney International · doi:10.1038/ki.1996.487 · Cited by 417
Rizzo, J. D., Lichtin, A. E., Woolf, S. H., Seidenfeld, J., Bennett, C. L., Cella, D., Djulbegovic, B., Goode, M. J., Jakubowski, A. A., Lee, S. J., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.177 · Cited by 417
Fishbane, S., Frei, G. L., & Maesaka, J. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90151-5 · Cited by 377
The safety of intravenous iron dextran in hemodialysis patients
Fishbane, S., Ungureanu, V.-D., Maesaka, J. K., Kaupke, C. J., Lim, V., & Wish, J. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90463-1 · Cited by 272
Use of Recombinant Human Erythropoietin Outside the Setting of Uremia
Cazzola, M., Mercuriali, F., & Brugnara, C. (1997) · Blood · doi:10.1182/blood.v89.12.4248 · Cited by 262
Michael, B., Coyne, D. W., Fishbane, S., Folkert, V., Lynn, R., Nissenson, A. R., Agarwal, R., Eschbach, J. W., Fadem, S. Z., Trout, J. R., et al. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00314.x · Cited by 199
Self-citationQuirt, I. C., Robeson, C., Lau, C. Y., Kovacs, M., Burdette-Radoux, S., Dolan, S., Tang, S. C., McKenzie, M., Couture, F., & the Canadian Eprex Oncology Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.21.4126 · Cited by 149
for the Epoetin Alfa Study Group, Fallowfield, L. J., Gagnon, D. D., Zagari, M. J., Cella, D. F., Bresnahan, B. W., Littlewood, T. J., McNULTY, P. K., Gorzegno, G., & Freund, M. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600657 · Cited by 117
Kooistra, M. P., Niemantsverdriet, E. C., van Es, A., Mol-Beermann, N. M., Struyvenberg, A., & Marx, J. J. M. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.1.82 · Cited by 102
Coyne, D. W., Adkinson, F., Nissenson, A. R., Fishbane, S. N., Agarwal, R., Eschbach, J. W., Michael, B., Folkert, V. W., BATLLE, D. C., Trout, J. R., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00703.x · Cited by 98
Self-citationClinical use of the total dose intravenous infusion of iron dextran.
Auerbach, M., Witt, D., Toler, W. T., Fierstein, M., Lerner, R. G., & Ballard, H. S. (1988) · PubMed · Cited by 97
Self-citationMarkowitz, G. S., Ga, K., Re, F., Coco, M., & Ri, L. (1997) · PubMed · Cited by 96
Sepandj, F., Jindal, K., West, M. L., & Hirsch, D. J. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/oxfordjournals.ndt.a027260 · Cited by 82
Auerbach, M., Chaudhry, M. A., Goldman, H., et al. (1998) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(98)90098-1 · Cited by 64
Self-citationSupplemental Iron: A Key to Optimizing the Response of Cancer‐Related Anemia to rHuEPO?
Henry, D. H. (1998) · The Oncologist · doi:10.1634/theoncologist.3-4-275 · Cited by 47
Cited by
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Tolkien, Z., Stecher, L., Mander, A. P., Pereira, D. I. A., & Powell, J. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117383 · Cited by 833
Anemia and Patient Blood Management in Hip and Knee Surgery: A Systematic Review of the Literature
Spahn, D. R. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181e08e97 · Cited by 650
The Safety of Intravenous Iron Preparations
Avni, T., Bieber, A., Grossman, A., Green, H., Leibovici, L., & Gafter-Gvili, A. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.10.007 · Cited by 441
Detection, evaluation, and management of iron-restricted erythropoiesis
Goodnough, L. T., Nemeth, E., & Ganz, T. (2010) · Blood · doi:10.1182/blood-2010-05-286260 · Cited by 410
Metadata
- Authors
- Auerbach, M., Ballard, H., Trout, J. R., McIlwain, M., Ackerman, A., Bahrain, H., Balan, S., Barker, L., & Rana, J.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-04-01
- Volume
- 22
- Issue
- 7
- Pages
- 1301-1307
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2147453280
- Cited by
- 414
- References
- 23
- FWCI
- 19.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.